Technical Data
Eck/EphA2 (EPHA2, EPH receptor A2, ARCC2, ECK, Ephrin type-A receptor 2, Epithelial cell kinase, Tyrosine-protein kinase receptor ECK) (PE)
EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands.
Protein kinases are enzymes that transfer a phosphate group from a phosphate donor, generally the g phosphate of ATP, onto an acceptor amino acid in a substrate protein. By this basic mechanism, protein kinases mediate most of the signal transduction in eukaryotic cells, regulating cellular metabolism, transcription, cell cycle progression, cytoskeletal rearrangement and cell movement, apoptosis, and differentiation.

Suitable for use in Flow Cytometry. Other applications have not been tested.

Recommended Dilutions:
Flow Cytometry: 1:5. Dilute with PBS. 10ul labels 1x10e6 in 100ul.
Optimal dilutions to be determined by the researcher.

Positive Control:
A431 cells

Storage and Stability:
May be stored at 4C before opening. DO NOT FREEZE! Stable at 4C as an undiluted liquid. Dilute only prior to immediate use. Stable for 12 months after receipt at 4C. Freezing R-Phycoerythrin (PE) conjugates will result in a substantial loss of activity. PE conjugates are sensitive to light.
MabIgG111C238Affinity Purified
100Tests4C Do Not FreezeBlue IceHumanMouse
Not Determined
Native protein isolated by purification of phosphotyrosine-containing proteins (NP_004422)
Purified by Protein G affinity chromatography
Supplied as a liquid in PBS, 15mg/ml BSA, 0.09% sodium azide. Labeled with R-Phycoerythrin (PE).
Recognizes human Epithelial Cell Kinase (Eck/EphA2).
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Carles-Kinch, K., et al. (2002). Cancer Res. 62:2840-7. 2. Hess, A.R., et al. (2001). Cancer Res. 61:3250-5. 3. Kinch, M.S., et al. (1998). Hybridoma. 17:227- 35. 4. Magal, E., et al. (1996). J. Neurosci. Res. 43:735-744. 5. Romer, L., et al. (1994). Mol. Biol Cell. 5:349- 361.